Interesting Engineering on MSN
US approves first nasal spray for major depressive disorder, PTSD conditions
Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has ...
SOUTH SAN FRANCISCO, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the ...
New Delhi: What began as a routine complaint of nasal blockage turned into one of the most extraordinary medical cases doctors at Manipal Hospital, Dwarka, ever encountered. A 33-year-old woman, ...
Small U.S. Phase 1 trial with newly optimized formulation to confirm favorable safety profile from three previous clinical trials and facilitate Phase 2B development of PH10 as a stand-alone treatment ...
The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially revolutionize Alzheimer‘s disease management. As populations ...
Add Yahoo as a preferred source to see more of our stories on Google. Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results